Traditionally we tend to identify and rank Emerging Experts, by defined metrics – their number of publications, their academic qualifications and awards, their involvement in trials or guid
You have a truly innovative medicine with a unique proposition in an area with a clear unmet need – in other words, a perfect recipe for advancing patient well-being and achieving brand lea
Sage Therapeutics has suffered another disappointment after deciding that it will have to drop the Parkinson’s programme for key pipeline drug dalzanemdor after it showed
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.